you are currently viewing:Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF, Benchmarking the Solactive US Biohealthcare IndexNovember 11, 2025-Solactive is pleased to announce its collaboration with Samsung Active Asset Management on the launch of the KoAct US Biohealthcare Active ETF,which uses the Solactive US Biohealthcare Index as a benchmark. The product aims to provide investors with targeted exposure to US-listed biotechnology and biopharmaceutical companies,reflecting the momentum of groundbreaking healthcare innovation. The US biohealthcare sector is undergoing a rapid transformation,reaffirming its role as the world's leading hub for biotechnology innovation. Advances in precision medicine,gene editing,and mRNA platforms are transitioning from research to commercialization,while artificial intelligence is accelerating drug discovery and development. Supported by regulatory initiatives from the US Food and Drug Administration (FDA),these innovations are shortening approval timelines and strengthening the country’s leadership in medical advancement. Source: Solactive AG |
November 10, 2025-The bonds mark Hong Kong's third digital bond sale since 2023 and are part of its push to become a leading global hub for tokenized assets.
November 9, 2025-Betashares has announced the launch of the Betashares Global Shares Ex US ETF (ASX: EXUS)- designed as a low-cost core portfolio building block to provide broad exposure to developed markets outside the US and Australia.
November 6, 2025-Introduction
Since the early 2000s,Asia has become a major engine of global growth,fuelled by industrialisation,technological innovation and deeper integration into global markets. As a result,the region today accounts for nearly a third of global GDP and 55% of the world's listed companies.